Azitra, Inc.

Azitra, Inc. (AZTR) priced its initial public offering on Jun 21, 2023 at $5.00 per share, raising $7.5M, and listed on NYSE American. At the IPO price its market capitalization was about $60.4M. ThinkEquity was lead-left underwriter. Greenberg Traurig advised the company and Venable advised the underwriters.

Azitra, Inc. is an early-stage clinical biopharmaceutical company developing therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Its platform includes a library of about 1,500 bacterial strains, screened with the help of AI and machine learning.

Status

IPO

Ticker

AZTR

Exchange

NYSE American

Priced

Jun 21, 2023

IPO price

$5.00

Raised

$7.5M

Market cap at IPO price

$60.4M

First filed

Feb 21, 2023

Underwriters

ThinkEquity

Company counsel

Greenberg Traurig

Underwriters' counsel

Venable

Sector

Biotech & pharma

Country / state

CT

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.